Yes, hypothyroidism can directly cause both depression and anxiety. The connection is biological, not coincidental. Thyroid hormones regulate key chemical messengers in your brain, and when those hormone levels drop, mood regulation suffers. In studies of people with Hashimoto’s thyroiditis (the most common cause of hypothyroidism), roughly 29 to 33% had a depressive disorder, compared to just 6% of healthy controls. Even mildly low thyroid function raises the risk of depression by about 78%.
How Thyroid Hormones Affect Your Brain
Your thyroid hormones don’t just control metabolism. They play a direct role in how your brain produces and uses serotonin, the chemical most closely linked to mood stability. When thyroid levels drop, serotonin activity in the outer layers of the brain decreases. At the same time, the brain’s self-regulating feedback loops for serotonin become overactive, further suppressing the serotonin signals that keep your mood stable. This is the same neurotransmitter system that most common antidepressants (SSRIs) are designed to boost.
Research in both humans and animal models confirms this pattern. People with hypothyroidism show reduced serotonin responsiveness on neuroendocrine tests, and that reduced responsiveness reverses when they start thyroid hormone replacement. In other words, fixing the thyroid fixes the serotonin problem in many cases. There’s also evidence that low thyroid function affects brain structure over time: lower levels of thyroid-stimulating hormone (TSH) have been associated with smaller hippocampus volume, and the hippocampus is a brain region central to both mood regulation and memory.
Subclinical Hypothyroidism Still Affects Mood
You don’t need a full-blown thyroid disorder to feel the psychiatric effects. Subclinical hypothyroidism, where TSH is slightly elevated but thyroid hormone levels still fall within the “normal” range, carries a statistically significant increase in depression risk. A meta-analysis pooling data from over 100,000 people found an odds ratio of 1.78 for depression in people with subclinical hypothyroidism compared to those with fully normal thyroid function. The prevalence of depression was 8.6% in the subclinical group versus 7.5% in controls.
This matters because subclinical hypothyroidism is common, affecting an estimated 4 to 10% of the general population, and many people with it are never tested or treated. If you’ve been told your thyroid is “borderline” or “fine” but you’re struggling with persistent low mood or anxiety, the subclinical range may still be contributing.
Thyroid Antibodies Can Cause Symptoms on Their Own
One of the more surprising findings in recent research involves thyroid autoimmunity. In Hashimoto’s thyroiditis, the immune system produces antibodies (called anti-TPO antibodies) that attack the thyroid gland. About 16.6% of the general population tests positive for these antibodies. And here’s the key point: people with elevated anti-TPO antibodies show higher rates of mood and anxiety disorders even when their actual thyroid hormone levels are completely normal.
Researchers describe this as a “low-thyroid function syndrome,” where the autoimmune process itself may disrupt brain chemistry before it causes measurable changes on standard blood tests. This helps explain why some people with Hashimoto’s feel depressed or anxious for months or years before they ever receive a thyroid diagnosis. In one comparative study, 52.9% of people with Hashimoto’s thyroiditis had a current psychiatric disorder, roughly triple the rate in healthy controls.
Symptoms That Overlap and Symptoms That Don’t
Hypothyroidism and major depression share a frustrating number of symptoms: fatigue, weight gain, difficulty concentrating, sleep problems, and a general feeling of sluggishness. This overlap is one reason thyroid problems get missed in psychiatric settings. A study of hospitalized psychiatric patients found that 10.5% had underlying hypothyroidism. Among those admitted for anxiety disorders specifically, the rate was 12.5%, and for depressive disorders it was 11.1%.
There are physical clues that point toward a thyroid problem rather than a primary psychiatric condition. Cold intolerance, dry or coarse skin, leg swelling, constipation, and a slow heart rate are hallmarks of hypothyroidism that don’t typically show up in depression alone. If you’re experiencing mood changes alongside these physical symptoms, a thyroid panel is worth requesting. Fatigue tends to be the most prominent symptom in hypothyroid patients and the one that most significantly reduces quality of life before treatment begins.
How Quickly Treatment Helps
The standard treatment for hypothyroidism is a daily synthetic thyroid hormone pill. For many people, mood symptoms improve as thyroid levels normalize, though it doesn’t happen overnight. Research from the American Thyroid Association found that depression scores improved after about three months of adequate thyroid hormone dosing. Interestingly, in one study of older patients, the mood improvement persisted even after the dose was reduced back to its original level, suggesting the brain may need a period of adequate thyroid signaling to reset its chemistry.
Not everyone sees complete resolution of depression or anxiety with thyroid treatment alone. Some people have both an independent mood disorder and a thyroid condition, and treating one doesn’t automatically resolve the other. But correcting the thyroid component removes a biological driver that can make depression harder to treat and antidepressants less effective.
Thyroid Hormones as a Tool for Treatment-Resistant Depression
The thyroid-mood connection runs deep enough that doctors sometimes use thyroid hormones to boost the effectiveness of antidepressants in people who haven’t responded to standard treatment. The synthetic form of the active thyroid hormone T3 has been studied as an add-on to both older and newer antidepressants.
The results are meaningful. In one trial, adding T3 to a tricyclic antidepressant produced a 59% response rate compared to 19% with placebo. When added to SSRIs in patients who hadn’t improved, response rates ranged from 35 to 42%, and remission rates (meaning symptoms essentially resolved) ranged from 25 to 36%. The large STAR*D trial, one of the biggest depression treatment studies ever conducted, found that about 23% of patients with treatment-resistant depression responded to T3 augmentation, with roughly 25% achieving full remission. T3 was also better tolerated than lithium, the other augmentation strategy tested.
These benefits have been observed even in patients whose thyroid levels were technically normal, reinforcing the idea that thyroid hormones influence brain chemistry in ways that go beyond what standard lab ranges capture.